Wockhardt Ltd.

₹2,179.4

-41.2 (-1.9%)

WOCKPHARMA Share Price

Pharmaceuticals & Biotechnology

As on September 11, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 35,560 Cr

P/E Ratio165.76

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	2,216.16	Bearish
10-DMA	2,075.87	Bullish
20-DMA	1,984.11	Bullish
50-DMA	1,935.93	Bullish
100-DMA	1,848.43	Bullish
200-DMA	1,598.61	Bullish

Historical Performance

1 Year

42.7%

3 Years

761.1%

5 Years

468.9%

10 Years

176%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	33,730	30,120	27,980	26,510	32,300
Total Expenditure	27,470	26,190	27,590	25,500	29,320
Other Income	1,370	620	830	1,220	200
Operating Profit	7,630	4,550	1,220	2,230	3,180
Interest	2,130	2,540	3,050	3,020	2,990
Depreciation	2,270	2,170	2,230	2,510	2,470
Profit Before Tax	2,380	-160	-4,200	-6,240	-4,110
Consolidated Net Profit	2,130	-470	-4,630	-5,590	-2,440
Adjusted EPS	13	-3	-30	-39	-17

Compounded Sales Growth

10 Years:-5.4

5 Years:4.5

3 Years:4.9

TTM:2.3

Compounded Profit Growth

10 Years:-3.2

5 Years:-20.9

3 Years:-33.3

TTM:9.4

Stock Price CAGR

10 Years:11.2

5 Years:41.7

3 Years:105.5

TTM:43.6

Return on Equity

10 Years:-16.3

5 Years:-16.9

3 Years:-30.1

last year:13.1

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	810	810	770	720	720
Total Reserves	48,460	42,610	32,690	32,660	37,590
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	12,350	8,870	6,170	-220	2,610
Other Current Liabilities	5,810	8,860	11,440	11,720	11,970
Short Term Borrowings	4,380	4,960	8,320	13,300	10,340
Total Liabilities	81,380	75,860	70,700	70,750	76,700
Capital Work in Progress	6,710	5,130	4,340	4,140	3,890
Long Term Loans & Advances	2,510	2,460	2,660	2,690	2,590
Currents Investments	4,120	4,220	---	---	---
Short Term Loans and Advances	3,960	4,620	2,860	3,350	3,520
Total Current Assets	26,060	24,650	20,730	19,140	24,450
Total Assets	81,380	75,860	70,700	70,750	76,700
Adjusted Book Value	304	268	217	232	266

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 165.76, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 105.5%, indicating sustained price appreciation.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹7630 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹33730 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1440259.1

No. of Shares: 661 (Approx)

Performance:44%

440259.1

NIFTY Performance: -6.8%

1 day Top Gainers